Clinical Significance of Early Pulmonary Hypertension in Preterm Infants

J Pediatr. 2022 Dec:251:74-81.e3. doi: 10.1016/j.jpeds.2022.07.039. Epub 2022 Aug 4.

Abstract

Objective: To characterize different phenotypes of early pulmonary hypertension (PH) in preterm infants and their respective associations with bronchopulmonary dysplasia (BPD) and survival.

Study design: A prospective cohort study in a tertiary university medical center from June 2016 until March 2019. Infants with a gestational age <30 weeks and/or a birth weight <1000 g were included. Echocardiographic assessment for PH was performed at 3-10 days after birth. Subsequent development of BPD at 36 weeks postmenstrual age and mortality were assessed.

Results: Early PH was identified in 55% of 104 included infants, including 21% with persistent PH of the newborn (PPHN), 61% with flow-associated PH, and 18% PH without shunt. Only PPHN was associated with placental fetal vascular malperfusion, lower gestational age, and low Apgar score. Both PPHN and flow PH were associated with the development of BPD. Early PH was associated with poorer survival, driven by PPHN.

Conclusions: Early PH is highly prevalent (55%) in preterm infants and associated with the development of BPD, independent of the phenotype of PH. Infants with PPHN had the poorest survival. Early PH presents in various phenotypes characterized by differences in etiology, pathophysiology, and associated long-term sequelae.

MeSH terms

  • Bronchopulmonary Dysplasia* / complications
  • Bronchopulmonary Dysplasia* / diagnosis
  • Female
  • Gestational Age
  • Humans
  • Hypertension, Pulmonary* / complications
  • Hypertension, Pulmonary* / etiology
  • Infant, Newborn
  • Infant, Premature
  • Placenta
  • Pregnancy
  • Prospective Studies